2026-01-06 - Analysis Report
Okay, here's a breakdown and analysis of Salesforce (CRM) based on the data provided.

**1) Return Rate Comparison**

*   **Company Overview:** Salesforce Inc. is a cloud-based software company providing customer relationship management (CRM) services.
*   **CRM Cumulative Return:** -10.62%
*   **VOO (S&P 500) Cumulative Return:** 91.00%
*   **Divergence:** -101.62% (Relative Divergence: 6.0)
*   **Analysis:** CRM has significantly underperformed the S&P 500. The divergence is substantial, indicating a large gap in returns. The relative divergence of 6.0 suggests the current divergence is near the minimum seen historically.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
|------------|-------|-------|--------|------|--------|
| 2016-2018  | 21.0% | 29.8% | 17.0%  | 1.4  | 131.8  |
| 2017-2019  | 15.0% | 29.8% | -2.0%  | 1.4  | 156.4  |
| 2018-2020  | 9.0%  | 29.8% | -11.0% | 1.1  | 214.1  |
| 2019-2021  | 33.0% | 21.2% | -10.0% | 1.1  | 244.4  |
| 2020-2022  | -73.0% | 59.8% | -71.0% | 1.2  | 127.5  |
| 2021-2023  | -42.0% | 59.8% | -43.0% | 1.4  | 253.1  |
| 2022-2024  | -37.0% | 52.3% | -56.0% | 1.4  | 321.6  |
| 2023-2025  | 10.0%  | 32.1% | -52.0% | 1.2  | 254.8  |

*   **CAGR:** Fluctuates significantly.
*   **MDD (Maximum Drawdown):** Indicates substantial risk, with drawdowns exceeding 50% in some periods.
*   **Alpha:** Consistently negative in recent periods, implying underperformance compared to the market.
*   **Beta:** Consistently above 1, indicating that CRM's price is more volatile than the overall market.
*   **Cap(B):** Market capitalization has generally increased over time, although this data doesn't reflect the recent price decline.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 253.62
*   **Previous Close:** 253.62
*   **Price Change:** 1.04
*   **5-day SMA:** 263.35
*   **20-day SMA:** 260.64
*   **60-day SMA:** 249.29
*   **Analysis:** The current price is below the 5-day and 20-day Simple Moving Averages (SMAs) but above the 60-day SMA. This suggests a recent downtrend but potentially some longer-term support. The small positive change from the previous day might indicate a slight rebound or consolidation.

**3) Technical Indicators and Analysis**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 37.53 (Approaching oversold territory)
*   **PPO:** -0.25 (Negative, indicating bearish momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-04)
*   **Recent Relative Divergence Change:** -0.9 (Short-term decline)
*   **Expected Return (%):** -749.7% (Very negative long-term outlook based on this model)
*   **Analysis:** The MRI suggests medium investment risk.  The RSI is nearing oversold conditions, which could signal a potential buying opportunity, but the negative PPO and significant expected negative return suggest caution. The recent decline in relative divergence confirms the short-term downward trend.

**4) Recent News & Significant Events**

*   **[2026-01-02] Salesforce.com (CRM) Stock Dips While Market Gains:** This headline reinforces the underperformance relative to the broader market.
*   **[2026-01-05] Salesforce: Take A Good Look At Agentforce Before You Invest (NYSE:CRM):** This suggests a need for careful consideration of specific product lines or strategic initiatives.
*   **[2026-01-02] 3 Big Rebound Stocks for 2026:** CRM is mentioned as a potential rebound stock, indicating some optimism despite recent struggles.
*   **[2026-01-02] Salesforce (CRM) Stock Trades Down, Here Is Why:** Suggests that there are specific factors driving the recent price decline.
*   **[2026-01-05] Analysts Love Salesforce Stock and Are Raising Their Price Targets - How to Play CRM:** This shows positive sentiment from analysts.
*   **[2026-01-02] Salesforce (CRM) Earnings Beat Highlights Expanding AI Adoption:** Good news about earnings, but there is no mention of whether it met expectations, or if outlook is positive.
*   **Analysis:**  The news is mixed. While some sources point to a potential rebound and analyst optimism, other headlines highlight current struggles and the need for caution. The mention of "AI adoption" is a positive sign, as it could be a growth driver.

**4-2) Analyst Opinions**

*   **Key:** None
*   **Mean (1=StrongBuy~5=Sell):** - (~-)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.06 / 475.00 / 223.00
*   **Recent Rating Changes:**  No data provided
*   **Analysis:** The high number of analyst opinions (53) suggests that CRM is widely followed. The average target price of $330.06 is significantly higher than the current price, implying that analysts generally believe the stock is undervalued. The lack of rating changes data makes it difficult to assess recent sentiment shifts.

**5) Recent Earnings Analysis**

| 날짜        | EPS  | 매출      |
|-------------|------|-----------|
| 2025-12-04 | 2.20 | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.60 | 9.44 B$ |
| 2025-12-04 | 1.60 | 9.44 B$ |

*   **Analysis:** Both EPS and Revenue have generally been increasing, suggesting positive fundamental performance. The latest EPS is strong (2.20).

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-10-31   | $10.26B    | 78.02%        |
| 2025-07-31   | $10.24B    | 78.10%        |
| 2025-04-30   | $9.83B     | 76.96%        |
| 2025-01-31   | $9.99B     | 77.81%        |
| 2024-10-31   | $9.44B     | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-10-31   | $60.02B    | 3.48% |
| 2025-07-31   | $61.33B    | 3.08% |
| 2025-04-30   | $60.67B    | 2.54% |
| 2025-01-31   | $61.17B    | 2.79% |
| 2024-10-31   | $58.52B    | 2.61% |

*   **Analysis:** Revenue has been steadily increasing, and profit margins are consistently high. Equity has been relatively stable, with a recent dip. ROE (Return on Equity) has shown some improvement in the most recent quarter, but the overall ROE is relatively low, suggesting that the company isn't generating as much profit from its equity as it could.

**7) Comprehensive Analysis**

CRM has significantly underperformed the S&P 500. While recent earnings and revenue growth are positive, there are concerns regarding ROE and the negative expected return. Recent news and analyst opinions are mixed. The technical indicators suggest a possible oversold condition, but also caution about the current downward trend. The MRI indicates medium investment risk. Overall, the picture is unclear. The company is generating good income, analysts are positive, and it may be in the early stages of a rally, but caution is advised.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.